106 related articles for article (PubMed ID: 26320538)
21. Reasons for rejecting th "flow theory" of calcified tissue metabolism.
Miller WA
Rev Can Biol; 1973 Dec; 32(4):281-9. PubMed ID: 4589476
[No Abstract] [Full Text] [Related]
22. Periodontal disease-associated compensatory expression of osteoprotegerin is lost in type 1 diabetes mellitus and correlates with alveolar bone destruction by regulating osteoclastogenesis.
Silva JA; Lopes Ferrucci D; Peroni LA; de Paula Ishi E; Rossa-Junior C; Carvalho HF; Stach-Machado DR
Cells Tissues Organs; 2012; 196(2):137-50. PubMed ID: 22301390
[TBL] [Abstract][Full Text] [Related]
23. [Osteoclasts in bone metabolism].
Hakeda Y; Kumegawa M
Kaibogaku Zasshi; 1991 Aug; 66(4):215-25. PubMed ID: 1759556
[TBL] [Abstract][Full Text] [Related]
24. Ca2+ or phorbol ester but not inflammatory stimuli elevate inducible nitric oxide synthase messenger ribonucleic acid and nitric oxide (NO) release in avian osteoclasts: autocrine NO mediates Ca2+-inhibited bone resorption.
Sunyer T; Rothe L; Kirsch D; Jiang X; Anderson F; Osdoby P; Collin-Osdoby P
Endocrinology; 1997 May; 138(5):2148-62. PubMed ID: 9112415
[TBL] [Abstract][Full Text] [Related]
25. New roles for osteoclasts in bone.
Boyce BF; Yao Z; Zhang Q; Guo R; Lu Y; Schwarz EM; Xing L
Ann N Y Acad Sci; 2007 Nov; 1116():245-54. PubMed ID: 18083932
[TBL] [Abstract][Full Text] [Related]
26. Safety of oral bisphosphonates: controlled studies on alveolar bone.
Jeffcoat MK
Int J Oral Maxillofac Implants; 2006; 21(3):349-53. PubMed ID: 16796276
[TBL] [Abstract][Full Text] [Related]
27. Vascular expression of the chemokine CX3CL1 promotes osteoclast recruitment and exacerbates bone resorption in an irradiated murine model.
Han KH; Ryu JW; Lim KE; Lee SH; Kim Y; Hwang CS; Choi JY; Han KO
Bone; 2014 Apr; 61():91-101. PubMed ID: 24401612
[TBL] [Abstract][Full Text] [Related]
28. [Selenium and organic diseases of the oral cavity].
Petrovich IuA; Podorozhnaia RP; Vavilova TP
Stomatologiia (Mosk); 1981; 60(2):68-72. PubMed ID: 7022756
[No Abstract] [Full Text] [Related]
29. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients.
Grassi F; Cristino S; Toneguzzi S; Piacentini A; Facchini A; Lisignoli G
J Cell Physiol; 2004 May; 199(2):244-51. PubMed ID: 15040007
[TBL] [Abstract][Full Text] [Related]
30. Bi-directionally selective bone targeting delivery for anabolic and antiresorptive drugs: a novel combined therapy for osteoporosis?
Liu J; Zhang H; Dong Y; Jin Y; Hu X; Cai K; Ma J; Wu G
Med Hypotheses; 2014 Dec; 83(6):694-6. PubMed ID: 25459136
[TBL] [Abstract][Full Text] [Related]
31. A useful method to evaluate bone resorption inhibitors, using osteoclast-like multinucleated cells.
Sugawara K; Hamada M; Hosoi S; Tamaoki T
Anal Biochem; 1998 Jan; 255(2):204-10. PubMed ID: 9451505
[TBL] [Abstract][Full Text] [Related]
32. Physiological and pharmacologic regulation of bone resorption--a 1978 update.
Raisz LG
J Periodontol; 1979 Apr; 50(4 Spec No):3-6. PubMed ID: 222886
[No Abstract] [Full Text] [Related]
33. The (mis) use of bone resorption markers in the context of bisphosphonate exposure, dental surgery and osteonecrosis of the jaw.
Don-Wauchope AC; Cole DE
Clin Biochem; 2009 Jul; 42(10-11):1194-6. PubMed ID: 19265689
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of T cell-dependent and RANKL-dependent osteoclastogenic processes associated with high levels of bone mass in interleukin-15 receptor-deficient mice.
Djaafar S; Pierroz DD; Chicheportiche R; Zheng XX; Ferrari SL; Ferrari-Lacraz S
Arthritis Rheum; 2010 Nov; 62(11):3300-10. PubMed ID: 20617528
[TBL] [Abstract][Full Text] [Related]
35. Clastic cells: mineralized tissue resorption in health and disease.
Arana-Chavez VE; Bradaschia-Correa V
Int J Biochem Cell Biol; 2009 Mar; 41(3):446-50. PubMed ID: 18840541
[TBL] [Abstract][Full Text] [Related]
36. Cellular biology and biochemical mechanism of bone resorption. A review of recent developments on the formation, activation, and mode of action of osteoclasts.
Vaes G
Clin Orthop Relat Res; 1988 Jun; (231):239-71. PubMed ID: 3286076
[TBL] [Abstract][Full Text] [Related]
37. [Bone and Stem Cells. Molecular mechanisms of the differentiation and activation of osteoclasts derived from hematopoietic cells].
Hayashi M; Nakashima T
Clin Calcium; 2014 Apr; 24(4):487-500. PubMed ID: 24681494
[TBL] [Abstract][Full Text] [Related]
38. Degradation of hydroxyapatite in vivo and in vitro requires osteoclastic sodium-bicarbonate co-transporter NBCn1.
Riihonen R; Nielsen S; Väänänen HK; Laitala-Leinonen T; Kwon TH
Matrix Biol; 2010 May; 29(4):287-94. PubMed ID: 20079835
[TBL] [Abstract][Full Text] [Related]
39. Open Thy Lattice Osteoclast, Resorb me!
Bakiri L
J Cell Biol; 2023 Apr; 222(4):. PubMed ID: 36928467
[TBL] [Abstract][Full Text] [Related]
40. New concepts in bone metabolism: clinical implications.
Mundy GR
Hosp Pract (Off Ed); 1991; 26 Suppl 1():7-12. PubMed ID: 1898515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
